Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

“These innovations elevate the standard of care for venous thromboembolism patients and will accelerate Stryker’s impact in endovascular procedures.” Inari had been working with advisers to ...

(RTTNews) - Stryker (SYK), Monday said it reached a deal to buy Inari Medical ... and will accelerate Stryker's impact in endovascular procedures." Under the deal, Stryker will commence a tender ...

Shares of Inari Medical catapulted to a 12-month high Monday on a report medical devices maker Stryker is in advanced talks ...

Inari Medical Inc (NASDAQ:NARI) shares surged sharply after Stryker (NYSE:SYK) announced that it would acquire the medical device maker in an all-cash deal valued at $4.9 billion The acquisition ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

After the MedTech giant Stryker (NYSE:SYK) agreed to offer $4.9B in cash to acquire Inari Medical (NASDAQ:NARI), a maker of clot removal systems, shares of its rival Penumbra (NYSE:PEN ...

Smith Collection / Gado / Getty Images Shares of Inari Medical surged Monday afternoon ... accelerate Stryker’s impact in endovascular procedures.” The companies expect the transaction to ...

Stryker (SYK) confirmed an agreement to purchase Inari Medical (NASDAQ:NARI) for about $4.9 billion. Inari jumped 21% in after hours trading. The medical devices firm will pay $80 a share in cash ...

The medical device maker plans to buy all of Inari’s common stock for $80 a share, representing a total fully diluted equity value of about $4.9 billion.

Stryker plans to acquire Inari Medical in a deal valued at $4.9 billion and designed to strength its position in the peripheral vascular market. The deal, announced Monday and approved by both ...

“These innovations elevate the standard of care for venous thromboembolism patients and will accelerate Stryker’s impact in endovascular procedures.” Drew Hykes, Chief Executive Officer, Inari, added, ...